A sporting event allowing the use of performance-enhancing drugs was held at a $50 million arena constructed in a casino parking lot in Las Vegas. The competition featured swimmers, sprinters, and weightlifters who openly used various substances typically banned in traditional athletic competitions.

Athletes at the event used a range of performance-enhancing substances including testosterone, methenolone, nandrolone, human growth hormone, and EPO. Additional substances included meldonium, modafinil, mixed amphetamine salts, clomiphene, anastrozole, levothyroxine, and liothyronine, administered through patches, capsules, creams, and pills.

The event attracted several dozen competitors across multiple athletic disciplines. Significant prize money was reportedly offered to participating athletes, though specific amounts were not detailed beyond references to millions of dollars being available.

The competition represents a departure from traditional athletic events where performance-enhancing drugs are strictly prohibited and can result in disqualification, suspensions, and stripped titles. Most major sporting organizations, including the International Olympic Committee and World Anti-Doping Agency, maintain comprehensive banned substance lists.

The Las Vegas venue was specifically constructed for hosting such events, indicating organized planning and investment in the concept of drug-enhanced athletic competition.